In response to Peshkin et al. “Genetic counseling and testing for hereditary cancer risk in young adult women: Facilitating autonomy and informed decision making is key”

Por Powell, C. Bethan, Richardson, Debra L., Chen, Lee-may
Publicado no Gynecol Oncol Rep (2015)

Risk of Occult Uterine Sarcoma in Women Undergoing Hysterectomy for Benign Indications

Por Kho, Kimberly A., Lin, Ken, Hechanova, Martin, Richardson, Debra L.
Publicado no Obstet Gynecol (2016)

Randomized Phase IIB Evaluation of Weekly Paclitaxel versus Weekly Paclitaxel with Oncolytic Reovirus (Reolysin®) in Recurrent Ovarian, Tubal, or Peritoneal Cancer: an NRG Oncology...

Por Cohn, David E., Sill, Michael W., Walker, Joan L., O'Malley, David, Nagel, Christa I., Rutledge, Teresa L., Bradley, William, Richardson, Debra L., Moxley, Katherine M., Aghajanian, Carol
Publicado no Gynecol Oncol (2017)

Paclitaxel With and Without Pazopanib for Persistent or Recurrent Ovarian Cancer: A Randomized Clinical Trial

Por Richardson, Debra L., Sill, Michael W., Coleman, Robert L., Sood, Anil K., Pearl, Michael L., Kehoe, Siobhan M., Carney, Michael E., Hanjani, Parviz, Van Le, Linda, Zhou, Xun C., Alvarez Secord, Angeles, Gray, Heidi J., Landrum, Lisa M., Lankes, Heather A., Hu, Wei, Aghajanian, Carol
Publicado no JAMA Oncol (2017)